The letter, sent to FDA Commissioner Robert Califf, requested documents and a briefing on how the agency is monitoring and working to end drug shortages, according to the publication.
“The FDA is failing to ensure vitally important pharmaceuticals remain on pharmacy shelves,” the lawmakers wrote, adding that the problem with shortages predates the COVID-19 pandemic.
In a statement shared with The Hill, the FDA indicated it had received the letter and will respond directly to the committee. It said it is working closely with manufacturers to mitigate the effects of shortages.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
